Name | Bismuth Subcitrate |
Classes |
Gastrointestinal Agent Antiulcerants |
Diseases |
Dysentry E. coli Infection Gastrointestinal Disease H. pylori Infection Ulcer |
Bismuth Subcitrate
Bismuth Subcitrate is a gastroprotective agent that belongs to the class of antacids. It works by forming a protective layer on the stomach's lining, thereby preventing damage caused by stomach acid.
Bismuth Subcitrate is used for the treatment of various gastrointestinal conditions, including:
- Peptic ulcers
- Gastritis
- Dyspepsia
- Gastroesophageal reflux disease (GERD)
The dosage of Bismuth Subcitrate varies depending on the patient's age, weight, and the severity of the condition being treated. The recommended dose is:
- Adults: 120 mg to 240 mg, taken four times daily, 30 minutes before meals and at bedtime.
- Children: The safety and efficacy of Bismuth Subcitrate in children have not been established.
Adverse reactions (sort by most common to least common and provide as bullet points): The following adverse reactions have been reported with the use of Bismuth Subcitrate:
- Constipation
- Blackening of the tongue and stool
- Nausea
- Vomiting
- Abdominal pain
- Headache
Before taking Bismuth Subcitrate, patients should consider the following warnings and precautions:
- Do not take Bismuth Subcitrate if allergic to bismuth or any other ingredient in the medication.
- Bismuth Subcitrate should not be used in patients with kidney disease, as it can cause accumulation of bismuth.
- Bismuth Subcitrate can interfere with the absorption of certain medications, such as tetracyclines and quinolones.
- Patients should inform their healthcare provider of any other medications they are taking before starting Bismuth Subcitrate.
- Bismuth Subcitrate can cause the tongue and stool to turn black, which is a harmless but temporary effect.
- Patients should not take Bismuth Subcitrate for more than two weeks without consulting a healthcare provider.
Contraindication
Bismuth Subcitrate is contraindicated in patients with a known allergy to bismuth or any other component of the medication.
None known.
None known.